Abstract
A Single Dose of Asenapine for the Treatment of Bipolar Patients Affected by Withdrawal Syndrome Induced Psychomotor Agitation: A Pilot, Open-Label Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have